Diabetes duration and obesity matter in autologous mesenchymal stem/stromal cell transplantation in type 2 diabetes patients

J Diabetes Investig. 2022 Feb;13(2):230-232. doi: 10.1111/jdi.13721. Epub 2021 Dec 15.

Authors

Joonyub Lee¹, Kun-Ho Yoon^{1

2}

Affiliations

¹ Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, Seoul St Mary's Hospital, The Catholic University of Korea, Seoul, Korea.
² Institute of Catholic Ubiquitous Health Care, The Catholic University of Korea, Seoul, Korea.

No abstract available

MeSH terms

Diabetes Mellitus, Type 2* / therapy
Humans
Mesenchymal Stem Cell Transplantation*
Obesity / complications
Obesity / surgery
Transplantation, Autologous